News

Mersana’s STING agonist ADC back on track in PhI after FDA lifts clinical hold

The FDA has lifted the full clinical hold on Mersana Therapeutics’ STING-targeted antibody-drug conjugate on the back of the company making Phase I study dosing alterations after a patient death. The FDA placed the hold on the trial in HER2-positive recurrent or metastatic solid tumors back in March. The… … […]

News

Local pharmacies say they’re struggling to afford GLP-1s

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Harry Webb has seen a flurry of interest in popular weight loss drugs at his independent pharmacies in Indiana, but he doesn’t know how much longer he can afford to stock… … […]

News

Immunitas Therapeutics Presents Data for Novel Anti CLEC2D-TLR9 Conjugate Program at the Society for Immunotherapy of Cancer 2023 Annual Meeting

In vitro proof-of-concept for novel myeloid and B cell modulating anti-CLEC2D-TLR9 agonist conjugate program, a compelling immunotherapeutic approach to induce T and NK cell recruitment in tumors with otherwise low immunological activity WALTHAM, Mass., Oct. 31, 2023 /PRNewswire/ –… … […]

News

Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth

WOBURN, Mass.–(BUSINESS WIRE)–Sanguine Biosciences, a leading biospecimen procurement services company that empowers patients to accelerate precision medicine and cell and gene therapy research and development, today announced that it secured $10 million in credit financing from Catalio Capital Management, a leading multi-strategy healthcare and life science investment firm. The loan… … […]

News

Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink

WALTHAM, Mass. & UPPSALA, Sweden–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions, today announced that Thermo Fisher has commenced the previously announced tender offer (the “Offer”) through a… … […]